SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-027487
Filing Date
2024-11-22
Accepted
2024-11-22 13:44:01
Documents
1
Period of Report
2024-11-18

Document Format Files

Seq Description Document Type Size
1 form3-11222024_061157.html 3  
1 form3-11222024_061157.xml 3 1689
  Complete submission text file 0001415889-24-027487.txt   3217
Mailing Address 64 RAMSHEAD ROAD RAYNHAM MA 02767
Business Address
ABRAMS MICHAEL S (Reporting) CIK: 0001497702 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38302 | Film No.: 241488675

Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801
Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Issuer) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)